Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (Bone Marrow Transplantation, (2020), 55, 11, (2071-2076), 10.1038/s41409-020-0919-0)

The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven’s name and affiliation. Bregje Verhoeven was incorrectly associated with Willem-Alexander Children’s Hospital, Department of Pediatrics, Leiden University Medical Center, Leid...

Full description

Bibliographic Details
Authors: Ljungman, Per, Mikulska, Malgorzata, de la Camara, Rafael, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte Palomino, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Murray, John, de Latour, Régis Peffault, Snowden, John A., Yakoub-Agha, Ibrahim, Verhoeven, Bregje, Kröger, Nicolaus, Styczynski, Jan
Format: article
Publication Date:2021
Country:España
Institution:Universidad Autónoma de Madrid
Repository:Biblos-e Archivo. Repositorio Institucional de la UAM
Language:English
OAI Identifier:oai:repositorio.uam.es:10486/694701
Online Access:http://hdl.handle.net/10486/694701
https://dx.doi.org/10.1038/s41409-020-0965-7
Access Level:Open access
Keyword:SARS-CoV-2
COVID-19
Hematopoietic cell transplantation (HCT)
CAR T cells
European Society for Blood and Marrow Transplantation (EBMT)
Medicina
Description
Summary:The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven’s name and affiliation. Bregje Verhoeven was incorrectly associated with Willem-Alexander Children’s Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. The correct affiliation is Foundation Hematon, Utrecht, The Netherlands. This has now been corrected in both the PDF and HTML versions of the article.

Similar Items